| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Graft Rejection | 39 | 2024 | 4228 | 2.850 |
Why?
|
| Vascular Endothelial Growth Factor A | 25 | 2016 | 3472 | 1.720 |
Why?
|
| Heart Transplantation | 16 | 2018 | 3073 | 1.520 |
Why?
|
| Skin Transplantation | 7 | 2018 | 1031 | 0.990 |
Why?
|
| Endothelium, Vascular | 19 | 2010 | 4423 | 0.970 |
Why?
|
| CD4-Positive T-Lymphocytes | 9 | 2021 | 4280 | 0.930 |
Why?
|
| Kidney Transplantation | 17 | 2024 | 4146 | 0.860 |
Why?
|
| TOR Serine-Threonine Kinases | 9 | 2022 | 2067 | 0.800 |
Why?
|
| Endothelial Cells | 10 | 2021 | 3514 | 0.780 |
Why?
|
| Transplantation, Homologous | 20 | 2018 | 4644 | 0.760 |
Why?
|
| Receptors, CXCR3 | 8 | 2012 | 236 | 0.740 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 4 | 2013 | 544 | 0.650 |
Why?
|
| Chemotaxis, Leukocyte | 4 | 2016 | 661 | 0.620 |
Why?
|
| Proto-Oncogene Proteins c-akt | 6 | 2015 | 2455 | 0.600 |
Why?
|
| Transplantation | 1 | 2019 | 217 | 0.600 |
Why?
|
| Neovascularization, Pathologic | 9 | 2015 | 2630 | 0.580 |
Why?
|
| Signal Transduction | 23 | 2019 | 23279 | 0.540 |
Why?
|
| CD40 Ligand | 10 | 2008 | 489 | 0.540 |
Why?
|
| Receptors, Chemokine | 5 | 2007 | 651 | 0.530 |
Why?
|
| Interferon-gamma | 6 | 2011 | 3125 | 0.520 |
Why?
|
| Chemokines, CXC | 4 | 2006 | 418 | 0.520 |
Why?
|
| T-Lymphocytes | 15 | 2021 | 10057 | 0.510 |
Why?
|
| Forkhead Transcription Factors | 4 | 2018 | 1597 | 0.510 |
Why?
|
| Neovascularization, Physiologic | 3 | 2012 | 1337 | 0.480 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2019 | 727 | 0.480 |
Why?
|
| Transcriptional Activation | 4 | 2012 | 1758 | 0.470 |
Why?
|
| Sirolimus | 9 | 2022 | 1535 | 0.460 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2022 | 2868 | 0.460 |
Why?
|
| Cells, Cultured | 20 | 2021 | 18941 | 0.450 |
Why?
|
| Nerve Growth Factors | 1 | 2016 | 562 | 0.440 |
Why?
|
| Immunosuppressive Agents | 10 | 2015 | 4077 | 0.440 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2018 | 3033 | 0.430 |
Why?
|
| Angiogenesis Inducing Agents | 2 | 2013 | 280 | 0.420 |
Why?
|
| Cell Adhesion Molecules | 6 | 2013 | 1601 | 0.410 |
Why?
|
| Vascular Endothelial Growth Factor C | 1 | 2013 | 124 | 0.410 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2019 | 4344 | 0.400 |
Why?
|
| Multiprotein Complexes | 4 | 2015 | 1123 | 0.400 |
Why?
|
| Organ Transplantation | 4 | 2022 | 1137 | 0.400 |
Why?
|
| TNF Receptor-Associated Factor 6 | 1 | 2012 | 62 | 0.400 |
Why?
|
| Cell Movement | 9 | 2018 | 5184 | 0.380 |
Why?
|
| T-Lymphocyte Subsets | 5 | 2012 | 1790 | 0.370 |
Why?
|
| Kidney Glomerulus | 3 | 2012 | 565 | 0.370 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2019 | 2900 | 0.370 |
Why?
|
| Lymphokines | 3 | 2003 | 929 | 0.370 |
Why?
|
| Protein Kinases | 2 | 2008 | 1613 | 0.370 |
Why?
|
| Microvessels | 1 | 2015 | 571 | 0.370 |
Why?
|
| Cell Proliferation | 7 | 2019 | 10394 | 0.370 |
Why?
|
| Chemokine CXCL10 | 7 | 2015 | 315 | 0.360 |
Why?
|
| Mice, SCID | 8 | 2016 | 2617 | 0.350 |
Why?
|
| Graft Survival | 9 | 2024 | 3657 | 0.320 |
Why?
|
| Postoperative Complications | 5 | 2016 | 15579 | 0.310 |
Why?
|
| Inflammation | 8 | 2013 | 10717 | 0.300 |
Why?
|
| Chemokines | 6 | 2013 | 959 | 0.300 |
Why?
|
| Immune Tolerance | 1 | 2017 | 2222 | 0.300 |
Why?
|
| Mice, Inbred BALB C | 7 | 2019 | 6121 | 0.300 |
Why?
|
| Hypertension, Renovascular | 1 | 2007 | 117 | 0.290 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2009 | 642 | 0.280 |
Why?
|
| Receptors, Cell Surface | 1 | 2016 | 2820 | 0.280 |
Why?
|
| Animals | 45 | 2022 | 167153 | 0.280 |
Why?
|
| Lymphocyte Activation | 7 | 2015 | 5418 | 0.280 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2015 | 2000 | 0.280 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2021 | 3322 | 0.270 |
Why?
|
| Endothelial Growth Factors | 3 | 2003 | 673 | 0.270 |
Why?
|
| Mitochondria | 1 | 2019 | 3574 | 0.270 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2007 | 208 | 0.270 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2016 | 2806 | 0.260 |
Why?
|
| Cyclosporine | 5 | 2019 | 752 | 0.250 |
Why?
|
| Radiopharmaceuticals | 1 | 2015 | 2671 | 0.250 |
Why?
|
| Transplantation Tolerance | 2 | 2018 | 568 | 0.250 |
Why?
|
| Monocytes | 5 | 2003 | 2562 | 0.250 |
Why?
|
| Chemokine CCL2 | 1 | 2007 | 598 | 0.240 |
Why?
|
| Mice | 30 | 2022 | 80750 | 0.240 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 5 | 2000 | 694 | 0.240 |
Why?
|
| Kidney | 4 | 2015 | 7009 | 0.240 |
Why?
|
| Cell Communication | 5 | 2013 | 1635 | 0.230 |
Why?
|
| Phosphatidylinositol 3-Kinases | 5 | 2018 | 2868 | 0.230 |
Why?
|
| Vascular Diseases | 1 | 2013 | 1178 | 0.230 |
Why?
|
| Sesquiterpenes | 1 | 2004 | 175 | 0.220 |
Why?
|
| Pulmonary Fibrosis | 1 | 2007 | 507 | 0.220 |
Why?
|
| Coronary Disease | 2 | 2016 | 5993 | 0.220 |
Why?
|
| Erythropoietin | 1 | 2007 | 717 | 0.220 |
Why?
|
| Peritoneal Dialysis | 1 | 2004 | 146 | 0.220 |
Why?
|
| Immunologic Memory | 1 | 2009 | 1331 | 0.210 |
Why?
|
| Promoter Regions, Genetic | 5 | 2012 | 5793 | 0.210 |
Why?
|
| Isoantigens | 3 | 2001 | 496 | 0.210 |
Why?
|
| Leukocytes | 6 | 2006 | 2030 | 0.210 |
Why?
|
| Gene Expression Regulation | 6 | 2015 | 11898 | 0.200 |
Why?
|
| Heart | 1 | 2015 | 4387 | 0.200 |
Why?
|
| Intercellular Adhesion Molecule-1 | 6 | 1995 | 1128 | 0.200 |
Why?
|
| Mice, Inbred C57BL | 7 | 2019 | 21793 | 0.200 |
Why?
|
| Mevalonic Acid | 1 | 2021 | 45 | 0.200 |
Why?
|
| CHO Cells | 2 | 2019 | 1389 | 0.190 |
Why?
|
| Humans | 85 | 2024 | 755562 | 0.190 |
Why?
|
| Histocompatibility Antigens | 2 | 2002 | 452 | 0.190 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2016 | 2476 | 0.180 |
Why?
|
| Cricetinae | 2 | 2019 | 2423 | 0.180 |
Why?
|
| Membrane Glycoproteins | 4 | 1999 | 3675 | 0.180 |
Why?
|
| Adoptive Transfer | 2 | 2019 | 793 | 0.180 |
Why?
|
| Fibroadenoma | 1 | 2000 | 41 | 0.180 |
Why?
|
| Endothelium | 4 | 1999 | 763 | 0.170 |
Why?
|
| Mycophenolic Acid | 1 | 2002 | 336 | 0.170 |
Why?
|
| Fibrocystic Breast Disease | 1 | 2000 | 103 | 0.170 |
Why?
|
| Telepathology | 1 | 2000 | 77 | 0.170 |
Why?
|
| CpG Islands | 1 | 2004 | 1208 | 0.170 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2003 | 1647 | 0.170 |
Why?
|
| Flow Cytometry | 4 | 2016 | 5846 | 0.160 |
Why?
|
| RNA, Messenger | 10 | 2015 | 12753 | 0.160 |
Why?
|
| Simvastatin | 1 | 2021 | 353 | 0.160 |
Why?
|
| Positron-Emission Tomography | 1 | 2015 | 6447 | 0.160 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 3 | 2009 | 557 | 0.160 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2004 | 723 | 0.160 |
Why?
|
| Complement C5a | 2 | 2018 | 100 | 0.160 |
Why?
|
| Phosphorylation | 4 | 2018 | 8320 | 0.160 |
Why?
|
| Blotting, Western | 4 | 2016 | 5044 | 0.150 |
Why?
|
| Lung Transplantation | 1 | 2007 | 1284 | 0.150 |
Why?
|
| Microfluidic Analytical Techniques | 4 | 2018 | 812 | 0.150 |
Why?
|
| Apoptosis | 7 | 2022 | 9452 | 0.150 |
Why?
|
| Cricetulus | 1 | 2019 | 816 | 0.150 |
Why?
|
| Tacrolimus | 2 | 2019 | 723 | 0.150 |
Why?
|
| Mice, Inbred C3H | 1 | 2018 | 911 | 0.140 |
Why?
|
| Interleukin-8 | 3 | 2018 | 701 | 0.140 |
Why?
|
| Transplantation Immunology | 1 | 1999 | 507 | 0.140 |
Why?
|
| Vascular Endothelial Growth Factors | 3 | 2003 | 749 | 0.140 |
Why?
|
| Hyperplasia | 1 | 2000 | 1155 | 0.140 |
Why?
|
| Repressor Proteins | 2 | 2005 | 2974 | 0.140 |
Why?
|
| Kidney Failure, Chronic | 3 | 2004 | 2426 | 0.130 |
Why?
|
| Myocardium | 4 | 2013 | 4673 | 0.130 |
Why?
|
| Umbilical Veins | 4 | 2006 | 425 | 0.130 |
Why?
|
| Jurkat Cells | 2 | 2009 | 730 | 0.130 |
Why?
|
| Methylation | 1 | 2018 | 1077 | 0.130 |
Why?
|
| Neuropilin-2 | 1 | 2015 | 55 | 0.130 |
Why?
|
| L-Selectin | 2 | 2011 | 207 | 0.130 |
Why?
|
| Primary Graft Dysfunction | 1 | 2016 | 108 | 0.130 |
Why?
|
| Kidney Diseases | 1 | 2006 | 2062 | 0.120 |
Why?
|
| Chronic Disease | 5 | 2015 | 9180 | 0.120 |
Why?
|
| Cadherins | 1 | 2019 | 903 | 0.120 |
Why?
|
| Biopsy, Needle | 1 | 2000 | 1632 | 0.120 |
Why?
|
| Renal Dialysis | 1 | 2004 | 1746 | 0.120 |
Why?
|
| Ammonia | 1 | 2015 | 236 | 0.120 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2004 | 2044 | 0.120 |
Why?
|
| Kidney Tubules, Proximal | 2 | 2007 | 379 | 0.120 |
Why?
|
| Isoantibodies | 1 | 2018 | 641 | 0.120 |
Why?
|
| Chemokine CXCL12 | 2 | 2014 | 453 | 0.120 |
Why?
|
| Time Factors | 7 | 2015 | 39963 | 0.110 |
Why?
|
| Microfluidics | 2 | 2018 | 655 | 0.110 |
Why?
|
| Kidney Neoplasms | 3 | 2022 | 4307 | 0.110 |
Why?
|
| Luciferases | 2 | 2013 | 718 | 0.110 |
Why?
|
| Mice, Knockout | 4 | 2019 | 14329 | 0.110 |
Why?
|
| Biopsy | 6 | 2024 | 6760 | 0.110 |
Why?
|
| Child | 17 | 2024 | 79428 | 0.110 |
Why?
|
| E-Selectin | 5 | 2006 | 577 | 0.110 |
Why?
|
| Ribosomal Protein S6 Kinases | 2 | 2015 | 203 | 0.110 |
Why?
|
| Child, Preschool | 12 | 2018 | 41893 | 0.110 |
Why?
|
| Chemokine CXCL11 | 1 | 2012 | 43 | 0.110 |
Why?
|
| P-Selectin | 1 | 1995 | 601 | 0.110 |
Why?
|
| Antigens | 2 | 2015 | 1442 | 0.110 |
Why?
|
| Interleukin-12 | 3 | 2001 | 578 | 0.100 |
Why?
|
| Diet, Carbohydrate-Restricted | 1 | 2015 | 260 | 0.100 |
Why?
|
| Receptors, CXCR | 1 | 2012 | 52 | 0.100 |
Why?
|
| HLA Antigens | 1 | 2018 | 1336 | 0.100 |
Why?
|
| RNA, Small Interfering | 3 | 2012 | 3449 | 0.100 |
Why?
|
| Receptor Cross-Talk | 1 | 2012 | 114 | 0.100 |
Why?
|
| Heart Failure | 1 | 2016 | 11781 | 0.100 |
Why?
|
| STAT1 Transcription Factor | 1 | 2013 | 333 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2013 | 476 | 0.100 |
Why?
|
| Lipoproteins, HDL | 1 | 2016 | 663 | 0.100 |
Why?
|
| Transcription Factors | 2 | 2008 | 12073 | 0.100 |
Why?
|
| Protein Binding | 4 | 2015 | 9309 | 0.100 |
Why?
|
| Benzodioxoles | 1 | 2012 | 75 | 0.100 |
Why?
|
| Receptors, CCR4 | 1 | 2011 | 77 | 0.100 |
Why?
|
| Predictive Value of Tests | 3 | 2016 | 15197 | 0.090 |
Why?
|
| Glomerulonephritis | 1 | 1993 | 338 | 0.090 |
Why?
|
| Calcineurin | 2 | 2009 | 228 | 0.090 |
Why?
|
| Inflammation Mediators | 2 | 2013 | 1874 | 0.090 |
Why?
|
| Chemotaxis | 2 | 2014 | 594 | 0.090 |
Why?
|
| Tissue Donors | 2 | 2018 | 2250 | 0.090 |
Why?
|
| Foreskin | 1 | 2010 | 31 | 0.090 |
Why?
|
| Models, Immunological | 2 | 2003 | 505 | 0.090 |
Why?
|
| Heme Oxygenase-1 | 3 | 2007 | 363 | 0.090 |
Why?
|
| Cardiopulmonary Bypass | 1 | 1995 | 1091 | 0.090 |
Why?
|
| Transplants | 1 | 2012 | 205 | 0.090 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2015 | 567 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 4574 | 0.090 |
Why?
|
| Male | 21 | 2019 | 356589 | 0.090 |
Why?
|
| src-Family Kinases | 1 | 2012 | 534 | 0.080 |
Why?
|
| Transcription, Genetic | 3 | 2004 | 7577 | 0.080 |
Why?
|
| Disease Models, Animal | 6 | 2015 | 18028 | 0.080 |
Why?
|
| Lung | 1 | 2007 | 9919 | 0.080 |
Why?
|
| Interleukin-4 | 1 | 1992 | 1114 | 0.080 |
Why?
|
| Reperfusion Injury | 2 | 2006 | 1015 | 0.080 |
Why?
|
| Microcirculation | 2 | 2007 | 1280 | 0.080 |
Why?
|
| ROC Curve | 1 | 2016 | 3555 | 0.080 |
Why?
|
| Membrane Proteins | 3 | 2015 | 7828 | 0.080 |
Why?
|
| Podocytes | 1 | 2012 | 407 | 0.080 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2007 | 57 | 0.070 |
Why?
|
| Receptors, CXCR4 | 1 | 2012 | 728 | 0.070 |
Why?
|
| Polyradiculoneuropathy | 1 | 1987 | 65 | 0.070 |
Why?
|
| Transplantation, Heterologous | 2 | 2010 | 2370 | 0.070 |
Why?
|
| Mice, Transgenic | 2 | 2018 | 9484 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 1616 | 0.070 |
Why?
|
| Stem Cells | 2 | 2013 | 3526 | 0.070 |
Why?
|
| Cholesterol | 1 | 2016 | 2920 | 0.070 |
Why?
|
| Oxygen | 1 | 2018 | 4177 | 0.070 |
Why?
|
| Models, Biological | 5 | 2015 | 9452 | 0.070 |
Why?
|
| Neutrophils | 2 | 2018 | 3735 | 0.070 |
Why?
|
| Antigen-Presenting Cells | 2 | 2001 | 944 | 0.070 |
Why?
|
| Glucose | 1 | 2018 | 4343 | 0.070 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 2 | 2018 | 221 | 0.070 |
Why?
|
| Coculture Techniques | 2 | 2001 | 1333 | 0.070 |
Why?
|
| Coronary Artery Disease | 2 | 2016 | 6616 | 0.070 |
Why?
|
| Adolescent | 11 | 2018 | 87237 | 0.060 |
Why?
|
| Biological Transport | 1 | 2010 | 2072 | 0.060 |
Why?
|
| Phenotype | 2 | 2021 | 16478 | 0.060 |
Why?
|
| Quinazolines | 1 | 2012 | 1356 | 0.060 |
Why?
|
| Lipopolysaccharides | 2 | 1992 | 2217 | 0.060 |
Why?
|
| Liver Circulation | 1 | 2005 | 159 | 0.060 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 1999 | 1415 | 0.060 |
Why?
|
| Nephritis | 1 | 2006 | 148 | 0.060 |
Why?
|
| Alternative Splicing | 2 | 2008 | 1094 | 0.060 |
Why?
|
| Cytokines | 6 | 2006 | 7263 | 0.060 |
Why?
|
| Transplantation, Heterotopic | 1 | 2004 | 168 | 0.060 |
Why?
|
| Infant | 8 | 2018 | 35867 | 0.060 |
Why?
|
| Cell Lineage | 1 | 2013 | 2512 | 0.060 |
Why?
|
| Regeneration | 1 | 2013 | 1504 | 0.060 |
Why?
|
| Cyclohexanes | 1 | 2004 | 150 | 0.060 |
Why?
|
| ras Proteins | 1 | 2009 | 1049 | 0.060 |
Why?
|
| Ligands | 2 | 2004 | 3286 | 0.060 |
Why?
|
| Tumor Microenvironment | 1 | 2017 | 3770 | 0.060 |
Why?
|
| HEK293 Cells | 1 | 2013 | 4233 | 0.060 |
Why?
|
| Organ Specificity | 2 | 2007 | 1955 | 0.060 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2004 | 296 | 0.060 |
Why?
|
| Metabolic Clearance Rate | 1 | 2004 | 362 | 0.060 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2002 | 5566 | 0.060 |
Why?
|
| Rats, Inbred F344 | 1 | 2004 | 807 | 0.060 |
Why?
|
| Heart Diseases | 2 | 2015 | 2798 | 0.060 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2010 | 4515 | 0.060 |
Why?
|
| Graft vs Host Reaction | 1 | 2003 | 103 | 0.060 |
Why?
|
| Mice, Nude | 3 | 2009 | 3589 | 0.060 |
Why?
|
| Biological Availability | 1 | 2004 | 396 | 0.050 |
Why?
|
| Gene Expression | 2 | 2011 | 7587 | 0.050 |
Why?
|
| Mammals | 1 | 2008 | 1134 | 0.050 |
Why?
|
| Drug Therapy, Combination | 2 | 2004 | 6481 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-3 | 1 | 2003 | 119 | 0.050 |
Why?
|
| Rats, Inbred Lew | 1 | 2004 | 1073 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2010 | 2667 | 0.050 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2004 | 188 | 0.050 |
Why?
|
| Protein Isoforms | 2 | 2006 | 1699 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 1 | 2015 | 4413 | 0.050 |
Why?
|
| Protein Biosynthesis | 2 | 2008 | 2116 | 0.050 |
Why?
|
| Drug Costs | 1 | 2010 | 1179 | 0.050 |
Why?
|
| Cell Line, Tumor | 6 | 2022 | 16795 | 0.050 |
Why?
|
| Antibodies | 1 | 2010 | 2415 | 0.050 |
Why?
|
| Research Design | 1 | 2018 | 6143 | 0.050 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 12500 | 0.050 |
Why?
|
| Trachea | 1 | 2007 | 1083 | 0.050 |
Why?
|
| Lignans | 1 | 2022 | 84 | 0.050 |
Why?
|
| Ischemia | 2 | 2007 | 1892 | 0.050 |
Why?
|
| Immunoenzyme Techniques | 2 | 1997 | 1708 | 0.050 |
Why?
|
| RNA Interference | 1 | 2010 | 2842 | 0.050 |
Why?
|
| Peritoneal Dialysis, Continuous Ambulatory | 1 | 2001 | 28 | 0.050 |
Why?
|
| Homeostasis | 1 | 2012 | 3287 | 0.050 |
Why?
|
| Syndrome | 1 | 2007 | 3276 | 0.050 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2003 | 590 | 0.050 |
Why?
|
| Administration, Cutaneous | 1 | 2003 | 712 | 0.050 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2000 | 215 | 0.050 |
Why?
|
| Immunohistochemistry | 5 | 2005 | 11028 | 0.050 |
Why?
|
| Female | 16 | 2018 | 387930 | 0.050 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2001 | 489 | 0.050 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2002 | 551 | 0.050 |
Why?
|
| Infant, Newborn | 4 | 2018 | 26039 | 0.050 |
Why?
|
| Glomerular Filtration Rate | 2 | 2012 | 2115 | 0.040 |
Why?
|
| Acute Disease | 4 | 2005 | 7224 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2008 | 2434 | 0.040 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2001 | 296 | 0.040 |
Why?
|
| Adult | 9 | 2015 | 217991 | 0.040 |
Why?
|
| Placebos | 1 | 2004 | 1667 | 0.040 |
Why?
|
| Safety | 1 | 2004 | 1147 | 0.040 |
Why?
|
| Epithelial Cells | 3 | 2007 | 3673 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2015 | 3779 | 0.040 |
Why?
|
| Risk Factors | 5 | 2018 | 73861 | 0.040 |
Why?
|
| Solubility | 1 | 2000 | 1084 | 0.040 |
Why?
|
| Microscopy, Video | 1 | 1999 | 242 | 0.040 |
Why?
|
| Living Donors | 2 | 2000 | 630 | 0.040 |
Why?
|
| Skin | 3 | 2000 | 4445 | 0.040 |
Why?
|
| Creatinine | 1 | 2024 | 1899 | 0.040 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2006 | 1701 | 0.040 |
Why?
|
| Medication Adherence | 1 | 2010 | 2150 | 0.040 |
Why?
|
| Abdomen | 1 | 2004 | 1114 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2008 | 4068 | 0.040 |
Why?
|
| Umbilical Cord | 1 | 1999 | 181 | 0.040 |
Why?
|
| Prospective Studies | 4 | 2018 | 53994 | 0.040 |
Why?
|
| NF-kappa B | 2 | 2005 | 2481 | 0.040 |
Why?
|
| Abdominal Pain | 1 | 2004 | 1062 | 0.040 |
Why?
|
| Chemotactic Factors | 1 | 2018 | 194 | 0.040 |
Why?
|
| Biphenyl Compounds | 1 | 2022 | 973 | 0.040 |
Why?
|
| Liver Diseases | 1 | 2006 | 1282 | 0.040 |
Why?
|
| Breast Neoplasms | 2 | 2006 | 20890 | 0.040 |
Why?
|
| Haplorhini | 1 | 1998 | 530 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2008 | 3440 | 0.040 |
Why?
|
| Human Growth Hormone | 1 | 2002 | 636 | 0.040 |
Why?
|
| Orbital Diseases | 1 | 1999 | 184 | 0.040 |
Why?
|
| Animals, Genetically Modified | 1 | 2002 | 1553 | 0.040 |
Why?
|
| Macrophages | 3 | 2006 | 5704 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2004 | 4887 | 0.030 |
Why?
|
| Antigen Presentation | 1 | 2002 | 1238 | 0.030 |
Why?
|
| Tamoxifen | 1 | 2001 | 960 | 0.030 |
Why?
|
| Histocompatibility Testing | 1 | 2018 | 688 | 0.030 |
Why?
|
| Headache | 1 | 2004 | 1238 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2004 | 4017 | 0.030 |
Why?
|
| Infant Mortality | 1 | 2001 | 750 | 0.030 |
Why?
|
| Antigens, CD | 2 | 1999 | 3910 | 0.030 |
Why?
|
| Interleukin-1 | 1 | 1999 | 1250 | 0.030 |
Why?
|
| Abscess | 1 | 1999 | 605 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2008 | 4942 | 0.030 |
Why?
|
| Adjuvants, Immunologic | 1 | 2001 | 1026 | 0.030 |
Why?
|
| Middle Aged | 7 | 2015 | 218062 | 0.030 |
Why?
|
| Treatment Outcome | 3 | 2015 | 64540 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2008 | 8439 | 0.030 |
Why?
|
| Growth Disorders | 1 | 2000 | 626 | 0.030 |
Why?
|
| Renal Insufficiency | 1 | 2001 | 811 | 0.030 |
Why?
|
| Chemokine CCL5 | 1 | 2015 | 214 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2015 | 21906 | 0.030 |
Why?
|
| Lymphoid Tissue | 1 | 1996 | 444 | 0.030 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2000 | 712 | 0.030 |
Why?
|
| Neoplasm Transplantation | 2 | 2008 | 2015 | 0.030 |
Why?
|
| Rats | 4 | 2006 | 23589 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2006 | 3606 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2005 | 2719 | 0.030 |
Why?
|
| Neoplasms | 4 | 2018 | 21887 | 0.030 |
Why?
|
| Autophagy | 1 | 2022 | 1329 | 0.030 |
Why?
|
| Transfection | 3 | 2007 | 5782 | 0.030 |
Why?
|
| Endothelin-1 | 1 | 2015 | 302 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2018 | 1908 | 0.030 |
Why?
|
| Observer Variation | 1 | 2000 | 2593 | 0.030 |
Why?
|
| Proteins | 1 | 2008 | 6029 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 3 | 2001 | 9109 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2002 | 2113 | 0.030 |
Why?
|
| Leukotriene B4 | 1 | 2014 | 281 | 0.030 |
Why?
|
| Kidney Tubular Necrosis, Acute | 1 | 1992 | 62 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2018 | 1248 | 0.030 |
Why?
|
| Glomerulonephritis, Membranoproliferative | 1 | 1992 | 39 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 2008 | 4295 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1999 | 1821 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2001 | 14384 | 0.030 |
Why?
|
| Lymphocyte Count | 1 | 2014 | 776 | 0.030 |
Why?
|
| Immunity | 1 | 2018 | 993 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2013 | 11871 | 0.030 |
Why?
|
| Prognosis | 3 | 2018 | 29424 | 0.020 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 39181 | 0.020 |
Why?
|
| Pulsatile Flow | 1 | 1993 | 320 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 2023 | 3120 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2003 | 25698 | 0.020 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 1992 | 283 | 0.020 |
Why?
|
| Cell Line | 2 | 2003 | 15646 | 0.020 |
Why?
|
| Papio | 1 | 1992 | 663 | 0.020 |
Why?
|
| Kidney Tubules | 1 | 1992 | 449 | 0.020 |
Why?
|
| Diastole | 1 | 1993 | 788 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2008 | 7343 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2013 | 10180 | 0.020 |
Why?
|
| Young Adult | 1 | 2016 | 58027 | 0.020 |
Why?
|
| Sinusitis | 1 | 1999 | 989 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2004 | 12348 | 0.020 |
Why?
|
| Age Factors | 2 | 2004 | 18366 | 0.020 |
Why?
|
| Liver | 1 | 2005 | 7473 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2015 | 1887 | 0.020 |
Why?
|
| Muscle, Skeletal | 2 | 2013 | 4910 | 0.020 |
Why?
|
| raf Kinases | 1 | 2009 | 119 | 0.020 |
Why?
|
| Ion Channels | 1 | 1994 | 1043 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2009 | 385 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2006 | 6312 | 0.020 |
Why?
|
| Urochordata | 1 | 1988 | 19 | 0.020 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1991 | 887 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 2013 | 1205 | 0.020 |
Why?
|
| Cadaver | 1 | 1992 | 1342 | 0.020 |
Why?
|
| Liver Transplantation | 1 | 2000 | 2292 | 0.020 |
Why?
|
| Ultrasonography, Interventional | 1 | 2016 | 1487 | 0.020 |
Why?
|
| Insurance, Pharmaceutical Services | 1 | 2010 | 345 | 0.020 |
Why?
|
| Actins | 1 | 2015 | 2055 | 0.020 |
Why?
|
| Urinary Bladder | 1 | 1994 | 1170 | 0.020 |
Why?
|
| Chemokine CXCL2 | 1 | 2007 | 108 | 0.020 |
Why?
|
| Postoperative Period | 1 | 1992 | 1820 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 9561 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 1993 | 3094 | 0.020 |
Why?
|
| GTPase-Activating Proteins | 1 | 2009 | 481 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2006 | 203 | 0.020 |
Why?
|
| Disease Progression | 2 | 2016 | 13429 | 0.020 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2005 | 47 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 1797 | 0.020 |
Why?
|
| Kinetics | 1 | 2013 | 6373 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2018 | 3036 | 0.020 |
Why?
|
| Reference Values | 1 | 1993 | 4914 | 0.020 |
Why?
|
| Stem Cell Transplantation | 1 | 2013 | 1601 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2006 | 613 | 0.020 |
Why?
|
| Collagen | 1 | 1993 | 2631 | 0.020 |
Why?
|
| Rabbits | 2 | 2006 | 4768 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2016 | 4554 | 0.010 |
Why?
|
| Ultrasonography | 2 | 1999 | 5938 | 0.010 |
Why?
|
| Myocardial Ischemia | 1 | 1995 | 2160 | 0.010 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 2004 | 91 | 0.010 |
Why?
|
| Genes, ras | 1 | 2006 | 653 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 1995 | 3483 | 0.010 |
Why?
|
| Risk Assessment | 2 | 2002 | 23957 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1992 | 1868 | 0.010 |
Why?
|
| Capillary Permeability | 1 | 2006 | 768 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2012 | 2822 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2007 | 1200 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2005 | 1759 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2009 | 2911 | 0.010 |
Why?
|
| Edema | 1 | 2006 | 771 | 0.010 |
Why?
|
| Survival Rate | 1 | 2016 | 12782 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1991 | 2520 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2012 | 4875 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2000 | 19987 | 0.010 |
Why?
|
| Hybridomas | 1 | 1982 | 442 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2007 | 79688 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 1173 | 0.010 |
Why?
|
| Th1 Cells | 1 | 2005 | 1000 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 9372 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 8013 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 1982 | 864 | 0.010 |
Why?
|
| Aging | 1 | 2018 | 8594 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2006 | 1396 | 0.010 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2006 | 936 | 0.010 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2006 | 1086 | 0.010 |
Why?
|
| Cell Division | 1 | 2006 | 4447 | 0.010 |
Why?
|
| Heart Defects, Congenital | 1 | 1995 | 4730 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2015 | 8953 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2006 | 3726 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2005 | 2107 | 0.010 |
Why?
|
| Wound Healing | 1 | 2008 | 2782 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2013 | 11444 | 0.010 |
Why?
|
| RNA | 1 | 2005 | 2712 | 0.010 |
Why?
|
| Recurrence | 1 | 1987 | 8441 | 0.010 |
Why?
|
| Bufonidae | 1 | 1994 | 12 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2000 | 58551 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2001 | 3469 | 0.010 |
Why?
|
| Dermatitis | 1 | 1996 | 200 | 0.010 |
Why?
|
| Informed Consent | 1 | 2000 | 997 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1994 | 317 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2006 | 4523 | 0.010 |
Why?
|
| Glomerular Mesangium | 1 | 1993 | 98 | 0.010 |
Why?
|
| Kidney Cortex | 1 | 1993 | 168 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1994 | 2183 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1994 | 1748 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2001 | 6364 | 0.010 |
Why?
|
| Methylprednisolone | 1 | 1992 | 385 | 0.010 |
Why?
|
| Lung Diseases | 1 | 2001 | 1905 | 0.010 |
Why?
|
| Cause of Death | 1 | 2001 | 3707 | 0.010 |
Why?
|
| Species Specificity | 1 | 1994 | 2410 | 0.010 |
Why?
|
| Appendicitis | 1 | 1996 | 675 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2004 | 5784 | 0.010 |
Why?
|
| Epithelium | 1 | 1993 | 1610 | 0.000 |
Why?
|
| Health Status | 1 | 2000 | 4056 | 0.000 |
Why?
|
| Prednisone | 1 | 1992 | 1564 | 0.000 |
Why?
|
| Aged | 1 | 2000 | 167382 | 0.000 |
Why?
|
| Mental Health | 1 | 2000 | 3178 | 0.000 |
Why?
|
| Comorbidity | 1 | 2001 | 10538 | 0.000 |
Why?
|
| Cell Membrane | 1 | 1994 | 3686 | 0.000 |
Why?
|
| Registries | 1 | 2000 | 8405 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1999 | 12926 | 0.000 |
Why?
|
| Random Allocation | 1 | 1988 | 2390 | 0.000 |
Why?
|
| Practice Guidelines as Topic | 1 | 2000 | 7434 | 0.000 |
Why?
|
| Secretory Rate | 1 | 1982 | 82 | 0.000 |
Why?
|
| B-Lymphocytes | 1 | 1996 | 4706 | 0.000 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1993 | 8168 | 0.000 |
Why?
|
| Base Sequence | 1 | 1993 | 12444 | 0.000 |
Why?
|
| Arthritis, Rheumatoid | 1 | 1996 | 3758 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1993 | 17611 | 0.000 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 1982 | 544 | 0.000 |
Why?
|
| Genes | 1 | 1982 | 1845 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1999 | 20404 | 0.000 |
Why?
|
| Chromosome Mapping | 1 | 1982 | 4629 | 0.000 |
Why?
|